Cancer Treatment Reviews
Volume 29, Issue 3 , Pages 151-160, June 2003

Early diagnosis and surgical management of prostate cancer

  • Kate D Linton
  • ,
  • Freddie C Hamdy

      Affiliations

    • Corresponding Author InformationCorrespondence to: F.C. Hamdy MD, FRCSEd (Urol), Professor and Head of Urology, Academic Urology Unit, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, UK. Tel.: +44-0-114-271-2154; Fax: +44-0-114-271-2268

Academic Urology Unit, Division of Clinical Sciences (South), University of Sheffield, Sheffield, UK

Abstract 

Prostate cancer is a significant cause of morbidity and mortality in the United States and Europe. The natural ageing of the population as well as the continued and widespread use of diagnostic tests such as prostate specific antigen (PSA), has led to an increase in the numbers of men diagnosed with localised prostate cancer. Screening to identify organ-confined disease has provoked much public and scientific attention, but remains controversial. Radical prostatectomy is one of the most challenging urological procedures performed. Improvements in technique due to better understanding of pelvic anatomy have reduced complications, with acceptable standards and excellent results in high-volume institutions. Continual refinements in technique and the recent introduction of laparoscopic radical prostatectomy are likely to improve functional outcome further. However the effectiveness of surgery in improving survival and quality of life, in men with early prostate cancer remains to be determined. The results from large randomised controlled trials are eagerly awaited.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0305-7372(03)00096-3

doi:10.1016/S0305-7372(03)00096-3

Cancer Treatment Reviews
Volume 29, Issue 3 , Pages 151-160, June 2003